Document ID: FDA-2009-N-0667-0007
Agency: fda
Document Type: Notice
Title: Amendment to Memorandum of Understanding Between the Food and Drug Administration and WebMD, LLC
Posted Date: 2009-11-05T05:00Z

[Federal Register: November 5, 2009 (Volume 74, Number 213)]
[Notices]               
[Page 57316-57318]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr05no09-59]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2009-N-0667]
[FDA-2008-N-0043]

 
Amendment to Memorandum of Understanding Between the Food and 
Drug Administration and WebMD, LLC

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is providing notice of 
an amendment to a memorandum of understanding (MOU) between FDA's 
Office of External Relations and WebMD, LLC.

DATES: The amendment became effective October 14, 2009.

FOR FURTHER INFORMATION CONTACT: Jason Brodsky, Office of External 
Relations (HFI-40), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-6251, e-mail: Jason.Brodsky@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: Under section VII, Assessment Mechanisms, of 
the October 2008 MOU (73 FR 73941, December 4, 2008 ), FDA and WebMD, 
LLC agree that the first paragraph of section VII of the October 2008 
MOU shall be replaced with the following paragraph:
    The October 2008 Memorandum of Understanding between the Food and 
Drug Administration and WebMD will continue as written for five years 
from the date of the signature by the latter Party to sign the October 
2009

[[Page 57317]]

Addendum to the Memorandum between the Food and Drug Administration and 
WebMD, L.L.C., whereupon the MOU may be renewed or terminated by mutual 
written consent. In addition, at any time, the Parties may modify or 
terminate the Agreement by mutual written consent, and either Party may 
modify or terminate the Agreement by mutual consent, and either Party 
may terminate the Agreement at any time by means of a written notice of 
termination.
    In accordance with 21 CFR 20.108(c), which states that all written 
agreements and MOUs between FDA and others shall be published in the 
Federal Register, the agency is publishing notice of this MOU.

    Dated: October 30, 2009.
David Horowitz,
Assistant Commissioner for Policy.
BILLING CODE 4160-01-S

[[Page 57318]]

[GRAPHIC] [TIFF OMITTED] TN05NO09.000

[FR Doc. E9-26674 Filed 11-4-09; 8:45 am]

BILLING CODE 4160-01-C